Non-alcoholic fatty liver disease (NAFLD): A tale of fat and sugar?

Fibrogenesis and Tissue Repair

Volumn 6, Issue 1, 2013, Pages

  Longato, Lisa ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Fructose; High fat diet; High fructose corn syrup; Mice; NAFLD; Non alcoholic steatohepatitis; Rats; Western diet

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; FAT INTAKE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; RAT; RISK FACTOR; SUGAR INTAKE;

EID: 84880181623     PISSN: None     EISSN: 17551536     Source Type: Journal    
DOI: 10.1186/1755-1536-6-14     Document Type: Article

References (22)

1. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ: The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012, 142:1592-1609.
2. Anania FA: Non-alcoholic fatty liver disease and fructose: bad for us, better for mice. J Hepatol 2011, 55:218-220.
3. Lim JS, Mietus-Snyder M, Valente A, Schwarz JM, Lustig RH: The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol 2010, 7:251-264.
4. Samuel VT: Fructose induced lipogenesis: from sugar to fat to insulin resistance. Trends Endocrinol Metab 2011, 22:60-65.
5. Vos MB, Lavine JE: Dietary fructose in nonalcoholic fatty liver disease. Hepatology 2013, 57:2525-2531.
6. Nomura K, Yamanouchi T: The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease. J Nutr Biochem 2012, 23:203-208.
7. Yilmaz Y: Review article: fructose in non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2012, 35:1135-1144.
8. Charlton M, Krishnan A, Viker K, Sanderson S, Cazanave S, McConico A, Masuoko H, Gores G: Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition. Am J Physiol Gastrointest Liver Physiol 2011, 301:G825-G834.
9. Tetri LH, Basaranoglu M, Brunt EM, Yerian LM, Neuschwander-Tetri BA: Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am J Physiol Gastrointest Liver Physiol 2008, 295:G987-G995.
10. Kohli R, Kirby M, Xanthakos SA, Softic S, Feldstein AE, Saxena V, Tang PH, Miles L, Miles MV, Balistreri WF, Woods SC, Seeley RJ: High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatology 2010, 52:934-944.
11. Wada T, Kenmochi H, Miyashita Y, Sasaki M, Ojima M, Sasahara M, Koya D, Tsuneki H, Sasaoka T: Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and highfructose diet. Endocrinology 2010, 151:2040-2049.
12. Feillet-Coudray C, Sutra T, Fouret G, Ramos J, Wrutniak-Cabello C, Cabello G, Cristol JP, Coudray C: Oxidative stress in rats fed a high-fat high-sucrose diet and preventive effect of polyphenols: Involvement of mitochondrial and NAD(P)H oxidase systems. Free Radic Biol Med 2009, 46:624-632.
13. Sohet FM, Neyrinck AM, Pachikian BD, de Backer FC, Bindels LB, Niklowitz P, Menke T, Cani PD, Delzenne NM: Coenzyme Q10 supplementation lowers hepatic oxidative stress and inflammation associated with diet-induced obesity in mice. Biochem Pharmacol 2009, 78:1391-1400.
14. Alisi A, Da SL, Bruscalupi G, Piemonte F, Panera N, De VR, Leoni S, Bottazzo GF, Masotti A, Nobili V: Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease. Lab Invest 2011, 91:283-293.
15. Aragno M, Tomasinelli CE, Vercellinatto I, Catalano MG, Collino M, Fantozzi R, Danni O, Boccuzzi G: SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats. Free Radic Biol Med 2009, 47:1067-1074.
16. Axelsen LN, Lademann JB, Petersen JS, Holstein-Rathlou NH, Ploug T, Prats C, Pedersen HD, Kjolbye AL: Cardiac and metabolic changes in long-term high fructose-fat fed rats with severe obesity and extensive intramyocardial lipid accumulation. Am J Physiol Regul Integr Comp Physiol 2010, 298:R1560-R1570.
17. Roth CL, Elfers CT, Figlewicz DP, Melhorn SJ, Morton GJ, Hoofnagle A, Yeh MM, Nelson JE, Kowdley KV: Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and toll-like receptor activation. Hepatology 2012, 55:1103-1111.
18. Poudyal H, Campbell F, Brown L: Olive leaf extract attenuates cardiac, hepatic, and metabolic changes in high carbohydrate-, high fat-fed rats. J Nutr 2010, 140:946-953.
19. Tsuchiya H, Ebata Y, Sakabe T, Hama S, Kogure K, Shiota G: High-fat, highfructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice. Metabolism 2013, 62:62-69.
20. Kawasaki T, Igarashi K, Koeda T, Sugimoto K, Nakagawa K, Hayashi S, Yamaji R, Inui H, Fukusato T, Yamanouchi T: Rats fed fructose-enriched diets have characteristics of nonalcoholic hepatic steatosis. J Nutr 2009, 139:2067-2071.
21. Poudyal H, Panchal SK, Ward LC, Waanders J, Brown L: Chronic highcarbohydrate, high-fat feeding in rats induces reversible metabolic, cardiovascular, and liver changes. Am J Physiol Endocrinol Metab 2012, 302:E1472-E1482.
22. Panchal SK, Wong WY, Kauter K, Ward LC, Brown L: Caffeine attenuates metabolic syndrome in diet-induced obese rats. Nutrition 2012, 28:1055-1062.